Skip to content
healthcare.dev

Avopef

NDC 83831-144, etoposide, injection, from AVYXA Pharma, LLC.

Product NDC
83831-144
Status
Listed
Labeler
AVYXA Pharma, LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA220200
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83831-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ETOPOSIDE100 mg/5mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
83831-144-05838310144051 VIAL in 1 CARTON (83831-144-05) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/acc1e443-ef7b-486f-a638-710a20e81059
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=83831-144

Use it

Look up 83831-144 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83831-144 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83831-144. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.